Evidence map›Paper›PMID 21412228›Full record

ReviewMucosal immunology2011

The impact of mucosal infections on acquisition and progression of tuberculosis.

S Perry, R Hussain, J Parsonnet

Registry-linked trialAbstract readReview
In one paragraph

Review in Mucosal immunology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02740140 (Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02740140 completednot on this map

Epidemiology of H. Pylori Transmission and Immunoepidemiology of Concomitant Infections

TypeobservationalSponsorStanford UniversityRan2008 to 2013Enrolled1,750ConditionsCommunicable Diseases
3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Parasite infection and tuberculosis disease among children: a case-control study.The American journal of tropical medicine and hygiene · 2014
    Article
  9. Article
  10. The complication of coinfection.The Yale journal of biology and medicine · 2012
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

S PerryDivision of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA. shnperry@stanford.edu
R Hussain
J Parsonnet

Funding

EPIDEMIOLOGY OF HELICOBACTER PYLORI TRANSMISSIONR01AI042801 · NIAID · STANFORD UNIVERSITY · PI PARSONNET, JULIE · 1999 to 2010
$6.2M
Immunoepidemiology of Concomittant InfectionK23AI054443 · NIAID · STANFORD UNIVERSITY · PI PERRY, SHARON · 2004 to 2008
$657k
NIAID NIH HHS K23 AI054443NIAID NIH HHS R01 AI042801PHS HHS R01-42081
6 · The paper itself

Abstract

More than one-third of the world's population, or over 2 billion people, are infected with Mycobacterium tuberculosis, the causative pathogen of tuberculosis in humans. Why only 10% of those infected develop active disease while the remainder harbor latent infection remains one of the greatest scientific and public health mysteries. Bacterial persistence is characterized by a dynamic state of immunological tolerance between pathogen and host. The critical role of CD4(+) T cells in defense against intracellular pathogens became evident during epidemiological studies of HIV-1 infection, which showed a clear inverse relationship between CD4(+) T-cell count in peripheral blood and increased risk of infection with M. tuberculosis, pneumocystis and Toxoplasma gondii. There is also growing evidence of a common mucosal immune system, whereby immune cells activated at one mucosal site may disseminate to remote effector sites. In this commentary, we review emerging evidence from human studies that the outcome of M. tuberculosis infection is influenced by concurrent mucosal infections, using Helicobacter pylori and geohelminths as examples. Understanding how the complexity of microbial exposures influences host immunity may have important implications for vaccine development and therapeutic interventions.

Indexed as

AnimalsCD4-Positive T-LymphocytesDisease ProgressionHelicobacter pyloriHelminthsHost-Pathogen InteractionsHumansImmune ToleranceImmunity, MucosalInfectionsMycobacterium tuberculosisRiskTuberculosis, PulmonaryVirulence

Identifiers

PMID21412228
PMCPMC5480373

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.